$23.28
0.170.75%
In chiusura: -
$22.68
-0.60-2.59%
After hour: Jun 23, 9:29 AM EDT
Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (ARCA: THNR)
Ticker | Name | Share % | |
---|---|---|---|
LLY | Eli Lilly & Co. | 13.95% | |
CO | Novo Nordisk A/S ADR | 13.90% | |
LN | Developed Markets Astrazeneca Plc Sponsored Adr | 4.66% | |
AMGN | Amgen Inc. | 4.60% | |
PFE | Pfizer, Inc. | 4.69% | |
JP | Chugai Pharmaceutical Co Ltd | 5.60% | |
SM | Roche Holding Ag | 4.64% | |
MRK | Merck & Co. Inc. | 4.77% | |
WST | West Pharmaceutical Services Inc | 4.67% | |
TMO | Thermo Fisher Scientific Inc | 5.01% | |
SH | Innovent Biologics Inc | 6.61% | |
TEVA | Teva Pharmaceutical Industries Ltd | 5.18% | |
HIMS | Hims & Hers Health Inc | 6.67% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
THNR segue uno stile di investimento Large Cap Blend.
Le principali posizioni di THNR includono: LLY (13.95%), CO (13.9%), LN (4.66%), AMGN (4.6%), PFE (4.69%). Queste rappresentano le posizioni più grandi nel portafoglio dell'ETF.
I dati del volume medio giornaliero per THNR non sono attualmente disponibili.